Coronavirus good news thread

SmallTown

Well-known member
But as mentioned, since you don't have the same 'cumulative effects' with vaccines that you might have with other therapeutic drugs, maybe it's possible to reduce the timescale of Phase 3 more safely? - I don't know.... just asking.
To be honest, taking a year IS reducing the timeframe. I think the longest clinical trial I've seen has been just over 7 years. A year is JUST ABOUT` enough time to get a good spread of trials with a good cross section of the population. I would be very cautious about any vaccine released before that. I mentioned earlier though, we have studied other coronavirus' and will have been trying to develop vaccines for them, so the only chance is shortcutting some of the trial by saying we already know how x or y works in the human body.
 

hopesoboro

Well-known member
Years working in the Pharma industry including working for quite a few biotech firms and one charity that staged trials has taught me that.
Moreover I’ve given you the scientific basis, that you need long term trials to test the efficacy over a general population and ensure there are no long term side effects
Pinnochio!
 

RandySavage

Well-known member
Chef at work was chosen for one of the random antibody finger pick tests that were sent out recently.
Came back positive for antibodies. Some may remember I said I was adamant I'd had the virus in January and it had spread round the kitchen at work.
Seems we were right.
 

bear66

Well-known member
Chef at work was chosen for one of the random antibody finger pick tests that were sent out recently.
Came back positive for antibodies. Some may remember I said I was adamant I'd had the virus in January and it had spread round the kitchen at work.
Seems we were right.
Are you having a test?
 
But it’s untrialed, right?
No, it's been through lab trials, animal trials, human trials phases 1 and 2 and is currently undergoing phase 3 trials in 4 different countries on 3 different continents involving around 60,000 volunteers. An additional phase 3 trial had just been announced for India, though it hasn't actually started yet and I don't know how many people would be involved.

Having said that, I'm not aware of any projected October rollout of the vaccine, at least not to the general public. At one time, they were projecting that if everything as well as it possibly could, they might be able to start giving it to certain high risk groups (such as front line health care workers) with an emergency use authorisation, sometime in the Autumn.

However the last "official" word I heard from anyone in the development team was an interview with Professor Andrew Pollard in late July, where they were looking at a date towards the end of the year for "registration" of the vaccine, as the following extract from a National Geographic article shows:
Preliminary results from all these [phase 3] trials will be collected through November, and if they confirm that the vaccine is effective, the Oxford team will submit it for an initial registration with MHRA by the end of the year.
As I understand it, registration would be only the first step in the final approval process so even that would not mean the vaccine would be available to the general public at that point.
 
Last edited:
Top